Cutler Group’s GenMark Diagnostics, Inc GNMK Stock Holding History

Cutler Group’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-300	Closed	-$1K	–	6749
2021 Q1	$1K	Buy	+300	New	+$5.58K	﹤0.01%	5511
2020 Q4	–	Sell	-9,600	Closed	-$10K	–	5786
2020 Q3	$10K	Buy	9,600 +3,500	+57%	+$53.5K	﹤0.01%	3034
2020 Q2	$13K	Buy	+6,100	New	+$62K	﹤0.01%	2715
2017 Q2	–	Sell	-1,800	Closed	-$3K	–	7410
2017 Q1	$3K	Buy	+1,800	New	+$21.7K	﹤0.01%	5282
2016 Q4	–	Sell	-1,100	Closed	-$2K	–	7644
2016 Q3	$2K	Buy	+1,100	New	+$10.6K	﹤0.01%	5892

Cutler Group's GNMK Position: Q2 2021 in Review

Cutler Group sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 4,504 shares — an estimated $107K sold.

Cutler Group first reported a position in GNMK in Q3 2016 and held it in 9 quarters. The position peaked at $107K in Q1 2021. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

Cutler Group reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
Cutler Group sold 4,504 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $107K.
Cutler Group first reported a position in GenMark Diagnostics, Inc in Q3 2016 and held it in 9 quarters.
Cutler Group's GenMark Diagnostics, Inc position peaked at $107K in Q1 2021.
0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on Cutler Group's 13F filing for Q2 2021, filed 19 Jul 2021.